Evidence map›Paper›PMID 31246002›Full record

ArticleACS chemical biology2019

Site-Resolved and Quantitative Characterization of Very Weak Protein-Ligand Interactions.

Brian Fuglestad, Nicole E Kerstetter, A Joshua Wand

Abstract read
In one paragraph

Article in ACS chemical biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Carnitine is a pharmacological allosteric chaperone of the human lysosomalJournal of enzyme inhibition and medicinal chemistry · 2021
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Brian FuglestadJohnson Research Foundation and Department of Biochemistry and Biophysics , Perelman School of Medicine at the University of Pennsylvania , Philadelphia , Pennsylvania , United States.
Nicole E KerstetterGraduate Group in Biochemistry and Molecular Biophysics , Perelman School of Medicine at the University of Pennsylvania , Philadelphia , Pennsylvania , United States.
A Joshua WandJohnson Research Foundation and Department of Biochemistry and Biophysics , Perelman School of Medicine at the University of Pennsylvania , Philadelphia , Pennsylvania , United States.ORCID 0000-0001-8341-0782

Funding

STRUCTURAL BIOLOGY TRAINING PROGRAMT32GM008275 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI WAND, A. JOSHUA · 1988 to 2018
$6.0M
Nanoscale Encapsulation for Fragment Based Drug DiscoveryR21CA206958 · NCI · UNIVERSITY OF PENNSYLVANIA · PI WAND, A. JOSHUA · 2016 to 2017
$385k
NCI NIH HHS R21 CA206958NIGMS NIH HHS T32 GM008275
6 · The paper itself

Abstract

Very weak interactions between small organic molecules and proteins have long been predicted and are expected to have dissociation constants of hundreds of millimolar and above. Unfortunately, quantitative evaluation of binding in a high-resolution structural context for this affinity regime is particularly difficult and often impossible using existing experimental approaches. Here, we show that nanoscale encapsulation of single protein molecules within the water core of reverse micelles enables the detection and evaluation of weak binding interactions at atomic resolution using solution NMR spectroscopy. This strategy is used to survey the interactions of a set of small molecules with the cytokine interleukin-1β (IL-1β). The interaction of IL-1β with these molecules is found to vary from more diffuse and weak binding modes to more specific and with a relatively higher affinity. The interactions detected here cover a large portion of the protein surface and have dissociation constants mostly in the low molar range. These results illustrate the ability of a protein to interact productively with a variety of small molecule functional groups and point to a broader potential to target even relatively featureless protein surfaces for applications in chemical biology and drug discovery.

Indexed as

Nuclear Magnetic Resonance, BiomolecularBinding SitesDrug DiscoveryHumansInterleukin-1betaLigandsMicellesModels, MolecularProtein BindingSolventsInterleukin-1betaLigandsMicellesSolvents

Identifiers

PMID31246002
PMCPMC7051831

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.